Dunhill Financial, LLC

Position in PFE — Pfizer Inc

CIK 1948904 LONDON, X0

Position in PFE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,733,224

-$383,740 QoQ

Shares Held

113,506

+2.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.47%

of 13F equity value

Holder Rank

#833

of 2,820 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Dunhill Financial, LLC holds $6,908,274 across 15 Drug Manufacturers - General names. PFE ranks #1 (39.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc This page	113,506	$2,733,224
2	ABBV	AbbVie Inc.	4,061	$1,021,910
3	JNJ	Johnson & Johnson	3,664	$930,546
4	LLY	ELI LILLY & Co	730	$875,583
5	AMGN	Amgen Inc	1,716	$621,397
6	NVS	Novartis AG	1,303	$204,206
7	BMY	Bristol Myers Squibb Co	1,889	$108,844
8	NVO	Novo Nordisk A S	1,972	$94,537

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,733,224	113,506	+2.3%	Shares	Sole	2026-08-07
2026-03-31	$3,116,964	111,003	+11.8%	Shares	Sole	2026-05-06
2025-12-31	$2,472,072	99,280	-8.2%	Shares	Sole	2026-01-29
2025-09-30	$2,756,146	108,169	+1.9%	Shares	Sole	2025-11-12
2025-06-30	$2,573,851	106,182	+1.6%	Shares	Sole	2025-08-05
2025-03-31	$2,649,043	104,540	+0.4%	Shares	Sole	2025-04-21
2024-12-31	$2,762,091	104,112	-1.1%	Shares	Sole	2025-02-14
2024-09-30	$3,048,047	105,323	+8848.4%	Shares	Sole	2024-11-15
2024-06-30	$32,932	1,177	+148.3%	Shares	Sole	2024-08-09
2024-03-31	$13,153	474	+19.7%	Shares	Sole	2024-05-13
2023-12-31	$11,400	396	-88.9%	Shares	Sole	2024-02-12
2023-09-30	$118,781	3,581	+0.1%	Shares	Sole	2023-10-27
2023-06-30	$131,277	3,579	—	Shares	Sole	2023-08-23
No filing history on record for this holder in this stock.